BCAL Diagnostics LimitedASX: BDX

Letter to Genetic Signatures Ltd Shareholders

· Issued by BCAL Diagnostics Limited via ASX

Filed with ASX · · 7 pages · English

Release

BCAL Diagnostics Limited ABN 51 142 051 223 Suite 506 Level 5 50 Clarence Street Sydney NSW 2000 15 October 2026 ASX Announcements BCAL Diagnostics Limited – Letter to Genetic Signatures Limited Shareholders As the largest shareholder in Genetic Signatures Limited (GSS), BCAL Diagnostics...

BCAL Diagnostics Limited on 6ix

Story so far

Earlier from BCAL Diagnostics

Later from BCAL Diagnostics

All BCAL Diagnostics news releases